Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases
- PMID: 31312902
- PMCID: PMC8583383
- DOI: 10.1007/s00270-019-02284-9
Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases
Abstract
role of liver-directed chemotherapy and loco-regional interventions in managing colorectal cancer liver metastases
Conflict of interest statement
Conflict of interest (COI)
Authors Jia Li, Ieva Kurilova, Juan C Camacho declare that they have no conflict of interest.
Nancy Kemeny received research fund from Amgen
Constantinos T. Sofocleous declare Research Support: Ethicon J&J, BTG, Consultant/Advisory Board: Terumo, Ethicon J&J, GE.
Similar articles
-
Liver-directed therapies in colorectal cancer.Semin Oncol. 2011 Aug;38(4):561-7. doi: 10.1053/j.seminoncol.2011.05.010. Semin Oncol. 2011. PMID: 21810515 Review.
-
Surgical treatment and other regional treatments for colorectal cancer liver metastases.Oncologist. 1999;4(3):197-208. Oncologist. 1999. PMID: 10394588 Review.
-
Nonresectional regional therapies for metastatic colorectal cancer to the liver.J Surg Oncol. 2019 Apr;119(5):636-641. doi: 10.1002/jso.25423. Epub 2019 Mar 1. J Surg Oncol. 2019. PMID: 30825217 Review.
-
Ablative and catheter-directed therapies for colorectal liver and lung metastases.Hematol Oncol Clin North Am. 2015 Feb;29(1):117-33. doi: 10.1016/j.hoc.2014.09.007. Hematol Oncol Clin North Am. 2015. PMID: 25475575 Review.
-
Management of potentially resectable colorectal cancer liver metastases.World J Gastrointest Surg. 2013 May 27;5(5):138-45. doi: 10.4240/wjgs.v5.i5.138. World J Gastrointest Surg. 2013. PMID: 23710291 Free PMC article.
Cited by
-
Association of RAS Mutation Location and Oncologic Outcomes After Resection of Colorectal Liver Metastases.Ann Surg Oncol. 2021 Feb;28(2):817-825. doi: 10.1245/s10434-020-08862-3. Epub 2020 Jul 18. Ann Surg Oncol. 2021. PMID: 32683635 Free PMC article.
-
Prospective Series of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver with 30-60 μm Microspheres Loaded with Irinotecan.Cardiovasc Intervent Radiol. 2023 Jul;46(7):880-890. doi: 10.1007/s00270-023-03446-6. Epub 2023 Jun 19. Cardiovasc Intervent Radiol. 2023. PMID: 37337059
-
Embolotherapy for Hepatic Oncology: Current Perspectives and Future Directions.Dig Dis Interv. 2020 Jun;4(2):134-147. doi: 10.1055/s-0040-1712146. Epub 2020 May 25. Dig Dis Interv. 2020. PMID: 32832829 Free PMC article. No abstract available.
-
The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases.Cancers (Basel). 2022 Mar 15;14(6):1503. doi: 10.3390/cancers14061503. Cancers (Basel). 2022. PMID: 35326651 Free PMC article. Review.
-
Personalized Image-Guided Therapies for Local Malignencies: Interdisciplinary Options for Interventional Radiology and Interventional Radiotherapy.Front Oncol. 2021 Apr 1;11:616058. doi: 10.3389/fonc.2021.616058. eCollection 2021. Front Oncol. 2021. PMID: 33869002 Free PMC article.
References
-
- National Cancer Institute Surveillance Epidemiology and End Results Program. Cancer Stat Facts: Colon and Rectum Cancer https://seer.cancer.gov/statfacts/html/colorect.html. Accessed May 17, 2018.
-
- Siegel RL, Miller KD, and Jemal A, Cancer statistics, 2018. CA Cancer J Clin, 2018. 68(1): p. 7–30. - PubMed
-
- Ghiringhelli F, et al., Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study. Dig Liver Dis, 2014. 46(9): p. 854–8. - PubMed
-
- Lee MS, Menter DG, and Kopetz S, Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes. J Natl Compr Canc Netw, 2017. 15(3): p. 411–419. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources